The Expression and Significance of MMP7 and TIMP1 in Andometriosis and Adenomyosis

In: Journal of Ningxia Medical University · 2011 · W2355562977
article OA: closed CC0
View on OpenAlex

Abstract

Objective To detect the expression and significance of MMP7 and TIMP1 in ovarian endometriosis and adenomyosis.Methods The expressions of MMP7 and TIMP1 were observed by immunihistochemisty in the ectopic and eutopic endometrium of 45 cases with ovarian endometriosis and adenomyosis and 33 controls with normal endometrium.Results The positive expression rate of MMP7 increased gradually from normal endometrium to eutopic endometrium and to ectopic endometrium.Significant statistical difference of IOD in MMP7 and TIMP1 were found between eutopic endometrium and normal endometrium,between eutopic endometrium and ectopic endometrium,and between ectopic endometrium and normal endometrium respectively.The positive expression rate of TIMP1 decreased gradually from normal endometrium to eutopic endometrium and to ectopic endometrium.Significant statistical difference of IOD in MMP7 and TIMP1 were found between eutopic endometrium and normal endometrium,between eutopic endometrium and ectopic endometrium,and between ectopic endometrium and normal endometrium respectively.Significant statistical difference of IOD in MMP7 and TIMP1 were found between eutopic endometrium and normal endometrium too.Conclusion The expression of MMP7 and TIMP1 may be the key role in occurrence of endometriosis and adenomyosis,and have no difference in occurrence of endometriosis and adenomyosis.

My notes (saved in your browser only)

Condition tags

endometriosisadenomyosis

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK